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Abstract
Background: Previous studies in occupational exposure and lung function have focused only on the main effect of
occupational exposure or genetics on lung function. Some disease-susceptible genes may be missed due to their low
marginal effects, despite potential involvement in the disease process through interactions with the environment.
Through comprehensive genome-wide gene-environment interaction studies, we can uncover these susceptibility
genes. Our objective in this study was to explore gene by occupational exposure interaction effects on lung function
using both the individual SNPs approach and the genetic network approach.
Methods: The study population comprised the Offspring Cohort and the Third Generation from the Framingham
Heart Study. We used forced expiratory volume in one second (FEV1)a n dr a t i oo fF E V 1 to forced vital capacity (FVC) as
outcomes. Occupational exposures were classified using a population-specific job exposure matrix. We performed
genome-wide gene-environment interaction analysis, using the Affymetrix 550 K mapping array for genotyping. A
linear regression-based generalized estimating equation was applied to account for within-family relatedness. Network
analysis was conducted using results from single-nucleotide polymorphism (SNP)-level analyses and from gene
expression study results.
Results: There were 4,785 participants in total. SNP-level analysis and network analysis identified SNP rs9931086
(Pinteraction =1.16 × 10
-7)i ng e n eSLC38A8, which may significantly modify the effects of occupational exposure on
FEV1. Genes identified from the network analysis included CTLA-4, HDAC,a n dPPAR-alpha.
Conclusions: Our study implies that SNP rs9931086 in SLC38A8 and genes CTLA-4, HDAC, and PPAR-alpha,w h i c ha r e
related to inflammatory processes, may modify the effect of occupational exposure on lung function.
Background
Chronic obstructive pulmonary disease (COPD) is defined
by decreased lung function, commonly measured by forced
expiratory volume in one second (FEV1)a n dt h er a t i oo f
FEV1 to forced vital capacity (FVC). Cigarette smoking is
the most important environmental risk factor for COPD.
However, COPD development in smoking populations is
not universal. In a study conducted by the American Thor-
acic Society [1], approximately 15% of COPD may be attrib-
utable to workplace exposures; a similar estimate was
reported in a more recent study [2]. Indeed, an association
between COPD or poor lung function and occupational ex-
posure to dust, gas, and fumes has been reported in both
industry-based studies [3-6] and community-based [7-11]
cross-sectional studies. In addition, mounting evidence in-
dicates that genetic factors contribute to COPD. In fact, the
disease aggregates in families [12], and genome-wide asso-
ciation studies (GWAS) [13-17] have identified single nu-
cleotide polymorphisms (SNPs) that are associated with
COPD or lung function.
To date, few study has comprehensively examined com-
bined genetic and environmental effects on lung function.
GWAS on lung function have considered genetic effects
alone; a recent review [18] showed that most GWAS find-
ings do not replicate consistently, which may imply a role
played by environmental exposures and gene-environmental
interactions. Studies of occupational exposure have only in-
vestigated the main effect of exposure on lung function.
Therefore, some disease susceptibility genes may be missed
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disease process through interactions with environmental ex-
posures [19]. Further, the majority of gene-environment
interaction studies of lung function or lung function has fo-
cused on gene by smoking interaction [20-23]. However, no
reports describe gene by occupational exposure interactions.
In addition, most researchers investigated SNPs or genes
through either in silico statistical methods or by gene ex-
pression experiments, but did not integrate these results.
Thus, an integrated, genome-wide gene-environment inter-
action study can more readily identify disease susceptibility
genes when environmental factors may also be contributing.
T h ep u r p o s eo ft h i ss t u d yw a st oi n v e s t i g a t eg e n eb y
occupational exposure interactions on FEV1 and FEV1/FVC
thorough SNP-level analysis and network analysis. Specifi-
cally, we first performed a GWAS using data from the
F r a m i n g h a mH e a r tS t u d y( F H S )t oi d e n t i f yS N P st h a ti n t e -
ract with occupational exposure using a population-specific
job exposure matrix (JEM) to affect (FEV1)a n dr a t i oo f
FEV1 to FVC. We next combined our GWAS SNP results
with gene expression results to build a network of bio-
logical processes that are driven by networks and not by
individual genes. The findings from these analyses unco-
vered several SNPs/Genes that may offer avenues for future
functional studies of genes contributing to lung function
changes following occupational exposures.
Methods
Study population
Our study population derivesf r o mt h eF H S[ 2 4 ] ,w h i c h
includes only Caucasians. This study has recruited partici-
pants since 1948; there have been three generations of par-
ticipants: the Original Cohort, their Offspring, and the Third
Generation. Spirometry measurements, detailed medical
history, physical examinations, and laboratory tests were
done approximately every two years. We used the 4,785 par-
ticipants with complete spirometry phenotypes, occupational
information, genotypes, and related covariates from the
Offspring Cohort and the Third Generation Cohort.
Ethics statement
W r i t t e ni n f o r m e dc o n s e n t sw e r ep r o v i d e db ya l lp a r -
ticipants. Protocols were approved by local institutional
review boards.
Spirometry phenotypes and covariates
Spirometry from participant lung function Exam 8 and
the Third Generation Exam were used in our study. We
used the FEV1 and FEV1 ratio (FEV1/FVC) as continuous
outcomes. Age, gender, height (inch), pack-years, and
smoking status were used as covariates in our analysis.
Smoking status (never, former, and current smokers) was
coded as dummy variable.
Genotyping and quality control
Genotyping for 500,568 SNPs was conducted with
approximately 550 K SNPs using the Affymetrix 500 K
mapping array plus Affymetrix 50 K supplemental array in
9,237 subjects from the three generations of participants.
We used 4,785 subjects from two generations in our study.
A quality test was conducted using the PLINK software
(version1.06, http://pngu.mgh.harvard.edu/~purcell/plink/).
A total of 499 individuals with genotyping call-rate <95%
were deleted, and the genotyping rate in the remaining
individuals was 98.6%. We conducted the Hardy-Weinberg
test for all SNPs, and found 19,546 SNPs had a p-value
<1 × 10
-6. These SNPs showed an obvious deviation from
the 45-degree line of a QQ plot and were excluded from
our analysis. A total of 34,110 SNPs had a per-SNP missing
rate >5% among all subjects and were excluded. We also
excluded 146,203 SNPs with minor allele frequency lower
than 5% in our study subjects. After filtering, 300,709 SNPs
remained for analysis.
Occupational exposure
We used a job exposure matrix (JEM) for occupational
exposure assessment. Occupational exposure was classi-
fied as high versus low likelihood for dust exposure
(coded as 1 and 0) according to their job categories
based on a questionnaire in Offspring Exam 8 and the
Third Generation Exam (Table 1). The questionnaire
asked, “Using the occupation coding sheet choose the
code that best describes your occupation”. There are 29
job categories (exclude retired) on the FHS occupation
coding sheet, and we classified 4 of them as highly likely
dust exposure including factory/assembly/mechanic,
skilled labor, general labor, and heavy labor, as modified
from UCSF COPD JEM (January, 2009 revision) [25].
Statistical analysis
SNP-level analysis
The family-based cohort was analyzed using linear
regression-based generalized estimating equations imple-
mented in the GWAF package for R [26] to account for
within-family relatedness. The within-pedigree corre-
lation matrix was modeled using an exchangeable work-
ing correlation matrix. We analyzed each SNP separately
using FEV1, and FEV1/FVC as outcomes. For each SNP,
we included age, gender, height (inch), pack-years, smoking
status, occupational exposure status, and tested for the
main SNP effect. We next fit an interaction model by
adding an SNP by occupational exposure status inter-
action to the model, and tested for the SNP-exposure
interaction.
Network analysis
To identify important networks among the genes that
interact with occupational exposure, we used Metacore
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networks using the gene lists. One gene list was ob-
tained from a previous study [27], in which human
airway epithelial cells obtained from 6 normal indi-
viduals were exposed to coarse, fine, or ultrafine par-
ticulate matter for 6 and 24 hours before gene
expression was assessed. The authors reported 71
unique genes altered by the particulate matter (PM).
To the best of our knowledge, no other studies have
focused on the effects of dust exposure or PM on
gene expression in human airway cells. Another list
of genes was generated from our results. We chose
SNPs whose interactions with occupational exposure
had p-values smaller than 10
-3 (around top 0.1% of
SNPs), and mapped these SNPs to genes to generate
a gene list. Gene annotation was performed using the
gene prediction track “RefSeqGenes” in the UCSC
browser (http://genome.ucsc.edu).
Results
This study comprised 4,785 participants, with 1,247 par-
ticipants from the Offspring Cohort and 3,538 participants
from the Third Generation. Among them, 4,238 partici-
pants were classified in the less likely dust exposure group
and 547 participants in the highly likely dust exposure
group.
Table 2 summarizes the characteristics for participants
by both exposure group and cohort. Mean FEV1 was
higher in the group with highly likely dust exposure, but
the mean FEV1/FVC was similar in the two groups overall.
However, the proportion of COPD cases (defined by
FEV1/FVC less than 70%) was higher in the group with
highly likely dust exposure. Lung function was higher and
the proportion of COPD cases was lower in the Third
Generation as compared to the Offspring Generation,
most likely attributable to the younger age of participants
in the Third Generation.
SNP-level analysis
The genome-wide analysis for 300,709 SNPs (Bonferroni
correctionα =1.66 × 10
-7) detected a significant inter-
action effect of SNP rs9931086 in gene SLC38A8 on
chromosome 16q23.3 and occupational exposure on FEV1
(Pinteraction=1. 16 × 10
-7). Further, gene-environment
interaction effects of SNPs rs3889785 and rs4234966 in
the MARCH1 gene and SNPs rs17508671, rs17430621,
and rs17508706 in the ZNF804A gene and occupational
exposure on FEV1 also had small P values (all Pinteraction
<3. 04×10
-5). The genomic inflation factor value of 1.045
calculated from the QQ plot suggested the p-values were
appropriately distributed. The results for the top 30 SNPs
with strongest occupational exposure interaction effects
on FEV1 are shown in Table 3 and the Manhattan plot is
shown in Figure S1 (see Additional file 1).
For gene by occupational exposure interaction effects on
FEV1/FVC, although no SNP reached the Bonferroni cor-
rected significance level (α=1. 66×10
-7), SNPs rs7297210,
rs6486961, rs7297431, and rs1875467 in gene AEBP2 and
SNPs rs10751811, rs2173524, and rs11595576 in ADARB2
had small P values (all Pinteraction<4. 32×10
-5). In addition,
SNP rs7314308 had small P values for both the main
genetic effect (PSNP=5. 43×10
-5) and the gene by occu-
pational exposure effect (Pinteraction=1. 20 × 10
-5). The
genomic inflation factor value of 1.043 suggested the
p-values were appropriately distributed. The results for
the top 30 SNPs with strongest occupational exposure
interaction effects on FEV1/FVC are shown in Table 4 and
the Manhattan plot is shown in Figure S2 (see Additional
file 1: Figure S2).
Networks analysis
With a cut-off p-value of 10
-3, we identified from our
GWAS data 450 SNPs in 142 genes that interacted with
Table 1 Job categories for dust exposure classification
Dust exposure group Job category
Highly likely dust
exposure
Factory/assembly/mechanic
Skilled labor (e.g., plumber, carpenter, painter, hairdresser)
General labor (e.g., custodian, delivery, mailman, truck driver)
Heavy labor (e.g., construction, landscaping)
Less likely dust
exposure
Nurse/medical personnel
Laboratory technician
Physical/occupational/speech therapist
Police/fire/security/military
Restaurant/food worker
Homemaker
Self-employed business owner
M.D./dentist/scientist/research
Lawyer/judge
Psychologist/social worker/mental health counselor
Engineer/computer science
Banker/accountant
Manager/consultant (e.g., production manager)
Administrative (e.g., personnel)
Educator
Secretary/clerk/data entry
retail/cashier
Sales/marketing/insurance
Realtor
Writer/editor/artist/graphic designer/craftsperson
Musician
Clergy (minister, priest, rabbi)
Sports pro/coach/exercise instructor/other
Statistician
Student
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116 genes that interacted with occupational exposure to
affect FEV1/FVC. From our gene list, we found three
network clusters consisting of 3, 6, and 13 genes. Inte-
grating the gene list obtained from the gene expression
study after exposure to PM, we found a network cluster
consisting of 55 genes; the three clusters identified from
our gene list are included in this big cluster (Figure 1).
The genes obtained from the gene expression results
linked all the network clusters together. Some key genes
that interacted with occupational exposure in the net-
work were HDAC, CTLA-4, PPAR-alpha, and OPRM1.
These genes play important roles in connecting different
network clusters into a big network cluster. In addition,
we found that all network clusters were centered by the
network cluster built from those genes identified from
the expression study after exposure to PM.
Discussion
To the best of our knowledge, this paper is the first study
assessing gene by occupational exposure interactions on
lung function using a community-based population. Our
results from SNP-level analysis suggest that SNP
rs9931086 in gene SLC38A8 may significantly modify the
effect of occupational exposure on FEV1. The results of
network analysis suggest that genes HDAC, PPAR-alpha,
and CTLA-4 play important roles in the gene by occupa-
tional exposure interaction network.
The novel locus, SNP rs9931086, in gene SLC38A8
had a significant gene by occupational exposure inter-
action effect on FEV1, although its genetic marginal
effect was not statistically significant. For each C allele
increase, the FEV1 decreased by 214 mL. We did not
identify this gene through the network analysis; this may
result, in part, from missing some genes that connect
SLC38A8 to the main gene network. For other top SNPs
in our study, SNP rs6941466 in SMOC2 (p= 3.21 × 10
-5)
was associated with FEV1/FVC through gene by occupa-
tional exposure interaction. SMOC2 has been previously
reported in both a gene main effect study [28] and a
gene by smoking interaction study [23]. Another top
SNP, rs1289714 (p=5.25 × 10
-4), in HHIP had a gene by
occupational exposure effect modification on FEV1/FVC.
The HHIP region was previously highlighted in the
GWAS of FEV1/FVC focus on gene main effect using
FHS data. The recent gene by smoking interaction on
lung function study [23] discovered three gene
regions, DNER, HLA-DQB1/HLA-DQA2, and KCNJ2/
SOX9, with significant SNPs. However, the p-values for
the SNPs in these genes were not statistically significant
in our study.
The genes we identified through the network analysis
are notable. Histone deacetylases (HDAC) are enzymes
that regulate inflammatory gene expression. Several
studies have shown the correlation between HDAC
activity and COPD disease severity, measured by FEV1
and FEV1/FVC, and that HDAC activity is reduced in
COPD patients [29-33]. Our results are consistent with
a recent large-scale GWAS that identified an HDAC4
association with lung function [34], which was also
found in the gene by smoking interaction study [23].
Another inflammation-related gene, PPAR-alpha,i sa n
isotype of the peroxisome proliferator-activated recep-
tors, which can regulate the induction of inflammatory
response [35]. One study showed that COPD patients
had higher percentages of PPAR-alpha-positive alveolar
Table 2 Characteristic of participants, stratified by cohort and dust exposure groups
Offspring Third generation Total
(n=1247) (n= 3538) (n=4785)
Less likely
dust exposure
Highly likely
dust exposure
Less likely
dust exposure
Highly likely
dust exposure
Less likely
dust exposure
Highly likely
dust exposure
(n= 1126) (n=121) (n=3112) (n=426) (n= 4238) (n=547)
Male, n (%) 444 (39.43) 100 (82.64) 1298 (41.71) 378 (88.73) 1742 (41.10) 478 (87.39)
FEV1, L±SD 2.71 ± 0.78 3.09 ± 0.75 3.54 ± 0.78 4.02 ± 0.71 3.32 ± 0.86 3.81 ± 0.82
FEV1/FVC, %± SD 0.73 ± 0.07 0.72 ± 0.08 0.78 ± 0.06 0.77 ± 0.06 0.77 ± 0.07 0.76 ± 0.07
FEV1/FVC<70%, n (%) 337 (29.93) 43 (35.54) 318 (10.22) 49 (11.50) 655 (15.46) 92 (16.82)
Age, years ±SD 62.83 ± 8.02 60.48 ± 7.87 39.81 ± 8.58 41.03 ± 8.57 45.93 ± 13.21 45.33 ± 11.66
Height, inches±SD 65.81 ± 3.76 67.99 ± 3.46 66.90 ± 3.65 69.29 ± 2.98 66.61 ± 3.71 69.01 ± 3.14
Pack-years
*± SD 21.40 ± 21.58 30.73 ± 23.32 12.56 ± 13.61 19.12 ± 15.90 15.50 ± 17.19 22.07 ± 18.74
Smoking status, n (%)
Never smokers 501 (44.49) 36 (29.75) 1854 (59.58) 177 (41.55) 2355 (55.57) 213 (38.94)
Former smokers 522 (46.36) 58 (47.93) 789 (25.35) 115 (27.00) 1311 (30.93) 173 (31.63)
Current smokers 103 (9.15) 27 (22.31) 469 (15.07) 134 (31.46) 572 (13.50) 161 (29.43)
*Pack-years mean and standard deviation calculated among current and former smokers.
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patients [36]. In addition, PPAR-alpha agonists may
enhance the inducible isoform of nitric oxide synthase
(iNOS) [37], and the expression of iNOS was found to
increase in patients with severe COPD [38].
CTLA-4, the cytotoxic T-lymphocyte antigen 4, plays a
role in downregulation of T-cell activation [39]. Further,
the amount of T-cells correlates with the severity of air-
way obstruction and alveolar damage [40-43]. Genome-
wide linkage analysis of the Boston Early-Onset COPD
Study also showed a significant peak for airflow limita-
tion on chromosome 2q, in the region of genes CTLA-4
and ICOS [44,45]. CTLA-4 gene polymorphisms are also
associated with chronic bronchitis or COPD [46,47].
In the network analysis, the cluster network built by
results of the gene expression experiment after PM
exposure was associated with cell cycle regulation. This
network of cell cycle regulation connected genes HDAC,
PPAR-alpha, CTLA-4 and may imply the possible under-
lying biological mechanism. Thus, the findings from
SNP-level analyses and network analyses complement
each other well. The genes found in our study are associ-
ated with inflammatory pathways. Genetic variation in the
ability to mount an inflammatory response may explain
varying individual responses to occupational exposure.
Importantly, we observed two genes through SNP-
level analysis (ZNF804A) and network analysis (OPRM1)
that interacted with occupational exposure to affect lung
Table 3 Top 30 strongest SNPs interacting with occupational exposure to affect FEV1
SNP Chr Position Band Gene All1 All2 MAF βSNP PSNP βinteraction Pinteraction
rs9931086 16 84046105 q23.3 SLC38A8 A C 0.19 27.70 2.53E-02 −214 1.16E-07*
rs11252277 10 4065704 p15.1 G A 0.09 2.90 1.05E-01 −263 6.32E-07
rs3889785 4 165097529 q32.3 MARCH1 A C 0.13 −2.02 1.69E-01 237 1.05E-06
rs7098287 10 4050329 p15.1 G C 0.09 3.60 4.88E-02 −247 2.47E-06
rs32977 5 14119057 p15.2 A G 0.06 5.50 7.38E-03 −310 3.98E-06
rs17508671 2 185491847 q32.1 ZNF804A A G 0.16 −0.27 8.32E-01 −173 4.45E-06
rs2544785 19 49085710 q13.33 SULT2B1 C T 0.16 0.03 0.983642 172 4.57E-06
rs4234966 4 165078580 q32.3 MARCH1 C G 0.12 −1.92 1.88E-01 217 6.35E-06
rs32978 5 14119645 p15.2 C T 0.05 5.05 1.75E-02 −302 6.63E-06
rs32979 5 14119775 p15.2 T C 0.05 5.05 1.75E-02 −302 6.63E-06
rs17645582 6 82797317 q14.1 C T 0.07 −1.07 5.75E-01 208 6.89E-06
rs4932559 15 92133594 q26.1 A G 0.36 −1.62 0.081898 132 7.10E-06
rs745926 2 120482057 q14.2 T G 0.41 −1.13 2.24E-01 136 9.90E-06
rs1561577 15 89146968 q26.1 A G 0.07 −3.17 0.104592 224 1.16E-05
rs6445707 3 54881562 p14.3 CACNA2D3 G A 0.18 0.40 7.47E-01 166 1.17E-05
rs2544784 19 49085733 q13.33 SULT2B1 A T 0.16 0.00 0.997879 161 1.25E-05
rs17110400 14 26276467 q12 C T 0.09 −0.31 0.855973 265 1.53E-05
rs10231843 7 103884705 q22.2 C G 0.27 −1.10 3.09E-01 160 1.64E-05
rs17430621 2 185492469 q32.1 ZNF804A A T 0.16 0.02 9.85E-01 −165 1.89E-05
rs163814 5 14122497 p15.2 C T 0.05 5.43 1.16E-02 −285 1.94E-05
rs477920 1 74767844 p31.1 FPGT TNNI3K A G 0.17 0.23 8.55E-01 −183 2.04E-05
rs6972824 7 157473222 q36.3 PTPRN2 C A 0.11 2.38 8.22E-02 −196 2.30E-05
rs6124623 20 42746332 q13.12 JPH2 C G 0.14 1.34 3.00E-01 −172 2.34E-05
rs2832081 21 30152992 q21.3 C A 0.31 −2.33 0.01353 137 2.36E-05
rs7356986 6 12301462 p24.1 G A 0.11 −1.68 3.20E-01 202 2.36E-05
rs41328144 1 166319711 q24.1 C T 0.13 −0.68 6.35E-01 155 2.54E-05
rs2803543 10 88301331 q23.2 G A 0.10 −2.35 1.49E-01 224 2.90E-05
rs163813 5 14122154 p15.2 G A 0.05 5.00 1.88E-02 −281 2.96E-05
rs17508706 2 185524591 q32.1 ZNF804A G A 0.16 −0.14 9.12E-01 −162 3.04E-05
rs4130671 7 119277137 q31.31 A C 0.49 −1.37 1.27E-01 122 3.71E-05
SNP-estimates are based on an additive model. Beta-estimates represent the increase or decrease FEV1 in mL.
*Significant after Bonferroni correction for testing 300,709 SNPs (α= 1.66E-07).
Chr: Chromosome; All1: allele1; All2: allele2.
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ered, these two genes are significantly associated with
many psychiatric diseases (e.g., schizophrenia, alcoholism,
and tobacco use disorder) in several studies [48-53]. The
comorbidity of abnormal pulmonary function or COPD
and psychiatric diseases has been reported in many studies
[54,55]. These psychiatric diseases might share some
common pathway with COPD. However, we must exercise
caution in interpreting these findings because smoking
prevalence is higher among psychiatric patients [56];
nonetheless, another study controlling for smoking found
schizophrenia to be an independent risk factor for
COPD [57].
It should be noted that this study has several limita-
tions. The first limitation is the lack of replication in
population studies that use similar methods as the FHS,
a community-based study with both occupational infor-
mation and genome-wide genotyping. Therefore, our re-
sults are more exploratory in nature. Further, SNP-
coverage was low for certain genes, which may
result in missing several genes that might interact with
occupational exposures. In addition, the mean FEV1 is
higher in the group with highly likely dust exposure.
This may be explained by gender distribution, since the
proportion of males was higher in the group with high
likelihood of dust exposure. Another potential expla-
Table 4 Top 30 strongest SNPs interacting with occupational exposure to affect FEV1/FVC
SNP Chr Position Band Gene All1 All2 MAF βSNP PSNP βinteraction Pinteraction
rs17051547 4 53421172 q12 C A 0.13 −0.44 3.31E-02 2.84 2.86E-06
rs17051550 4 53425943 q12 C G 0.11 −0.38 8.06E-02 2.91 6.01E-06
rs11671079 19 29900846 q12 LOC284395 G A 0.46 −0.10 0.397666 1.55 8.65E-06
rs2804576 10 113775409 q25.2 A G 0.13 0.34 9.56E-02 −2.83 1.01E-05
rs7314308 12 59684714 q14.1 G A 0.19 0.65 5.43E-05 −2.09 1.20E-05
rs7297210 12 19630207 p12.3 AEBP2 T C 0.40 0.18 2.22E-01 −1.62 1.53E-05
rs2655364 18 26229339 q12.1 T A 0.46 −0.20 1.43E-01 1.76 1.55E-05
rs4322259 1 64339246 p31.3 ROR1 C G 0.35 0.21 1.59E-01 −1.72 1.61E-05
rs1504108 18 26224965 q12.1 A G 0.45 −0.20 1.56E-01 1.76 1.82E-05
rs2655360 18 26231390 q12.1 T C 0.45 −0.20 1.54E-01 1.73 2.23E-05
rs987124 18 26217351 q12.1 G A 0.46 −0.20 1.38E-01 1.71 2.54E-05
rs9878581 3 37969695 p22.2 CTDSPL C G 0.13 −0.37 6.85E-02 2.23 2.92E-05
rs10751811 10 1687171 p15.3 ADARB2 A G 0.36 −0.17 2.46E-01 1.53 3.06E-05
rs6486961 12 19626815 p12.3 AEBP2 A G 0.40 0.13 3.60E-01 −1.59 3.13E-05
rs6941466 6 168929950 q27 SMOC2 T C 0.22 −0.21 2.54E-01 2.03 3.21E-05
rs7297431 12 19600232 p12.3 AEBP2 T C 0.45 0.15 2.75E-01 −1.59 3.30E-05
rs10770501 12 19683476 p12.3 G A 0.46 0.16 2.51E-01 −1.57 3.35E-05
rs537693 6 159662136 q25.3 FNDC1 G A 0.12 −0.11 6.18E-01 2.28 3.36E-05
rs2173524 10 1687799 p15.3 ADARB2 T G 0.35 −0.18 2.46E-01 1.51 3.41E-05
rs1105791 9 81179317 q21.31 C A 0.19 −0.36 0.026841 1.91 3.83E-05
rs1875467 12 19622345 p12.3 AEBP2 C A 0.46 0.13 3.43E-01 −1.54 4.06E-05
rs9888671 15 26277939 q12 LOC100128714 C T 0.13 0.17 3.79E-01 2.01 4.09E-05
rs12141717 1 55388480 p32.3 G A 0.29 −0.08 5.89E-01 1.80 4.24E-05
rs11595576 10 1688497 p15.3 ADARB2 T C 0.36 −0.16 2.96E-01 1.53 4.32E-05
rs5996665 22 24469115 q11.23 CABIN1 G A 0.08 0.35 8.54E-02 −2.65 4.41E-05
rs7078873 10 61787587 q21.2 ANK3 T A 0.38 0.30 3.34E-02 −1.62 4.49E-05
rs4938871 11 57329402 q12.1 UBE2L6 C A 0.26 −0.36 3.28E-02 1.90 4.63E-05
rs1885166 9 17610211 p22.2 SH3GL2 T C 0.39 0.10 0.487458 −1.70 4.77E-05
rs10052266 5 6010711 p15.32 G A 0.12 0.32 0.094656 −2.01 4.83E-05
rs2763249 6 168926062 q27 SMOC2 A G 0.22 −0.21 2.38E-01 1.97 4.89E-05
SNP-estimates are based on an additive model. Beta-estimates represent the increase or decrease FEV1/FVC in percentage.
Chr: Chromosome; All1: allele1; All2: allele2.
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[58-60]. Participants in the highly likely dust exposure
group were likely those in better health since most dusty
jobs (e.g. heavy labor) require workers to be in better
health. This bias may result in underestimation of the
occupational exposure effect and reduce the effect size
of our findings. Finally, our occupational exposure status
was classified based on a JEM having less detailed oc-
cupational information than the UCSF COPD JEM;
thus, our estimates may not reflect the true frequency.
The occupational information in our study derives
from a cross-sectional questionnaire, which may not
reflect the longest-held job (e.g., participants may have
worked in dusty job for 10 years but had switched to
an o n - d u s t yj o bb yt h et i m eo ft h es u r v e y ) .T h e s e
measurement errors might result in an underestima-
tion of the gene by occupational exposure interaction
association.
Our study indicates that integrating the results of a
gene expression experiment into the GWAS of gene-
environment interaction is informative for exploring
novel genes. Future studies should increase the SNP
coverage and measure occupational exposure more
precisely by collecting more detail occupational informa-
tion including the duration of each job and detail job titles.
Moreover, future research could focus on examining the
roles of CTLA-4, HDAC,a n dPPAR-alpha in the inflam-
matory airway process.
Figure 1 Network for genes interacting with occupational exposure to affect lung function. Network analysis revealed network clusters of
genes with occupational exposure interaction effects on lung function (circled) that are connected by the network cluster built from genes
affected by exposure to PM [27]. Genes modifying the occupational exposure effect on lung function are indicated by circles (FEV1) and
rectangles (FEV1/FVC). All other symbols are explained in the Metacore legend (http://ftp.genego.com/files/MC_legend.pdf).
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Our study found that SNP rs9931086 in the SLC38A8
gene and genes CTLA-4, HDAC, and PPAR-alpha, which
are involved in inflammatory processes, may modify the
effects of occupational exposure on lung function.
Additional file
Additional file 1: Figure S1. Manhattan plot for interacting SNP with
occupational exposure on FEV1. Figure S2. Manhattan plot for
interacting SNP with occupational exposure on FEV1/FVC.
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